Back to all papers

A reproducible structural brain axis of alcohol use severity.

November 19, 2026pubmed logopapers

Authors

Wiegert J,Oweda J,Lenz E,Volkmer S,Li X,Abas A,Mai A,Roetzer L,Meinert S,Leehr EJ,Hahn T,Flinkenflügel K,Borgers T,Völzke H,Dannlowski U,Bamberg F,Hermesdorf M,Karch A,Berger K,Klinger-König J,Grabe HJ,Pischon T,Krist L,Keil T,Leitzmann M,Pabst A,Riedel-Heller SG,Niendorf T,Nees F,Peters A,Baune BT,Ritter K,Kircher T,Jamalabadi H,Straube B,Javaheripour N,Stein F,Teutenberg L,Schulze MB,Greiser KH,Bach P,Streit F,Schwarz E

Affiliations (35)

  • Hector Institute for Artificial Intelligence in Psychiatry, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany. [email protected].
  • Department of Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany. [email protected].
  • Hector Institute for Artificial Intelligence in Psychiatry, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
  • Department of Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
  • Department of Addictive Behavior and Addiction Medicine, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
  • German Center for Mental Health (DZPG), Partner Site Mannheim - Heidelberg, Ulm, Germany.
  • Institute for Translational Psychiatry, University of Münster, Münster, Germany.
  • Institute for Community Medicine, University Medicine Greifswald, Greifswald, Germany.
  • Department of Psychiatry, Medical School and University Medical Center OWL, Protestant Hospital of the Bethel Foundation, Bielefeld University, Bielefeld, Germany.
  • German Center for Mental Health (DZPG), Site Jena Magdeburg Halle, Halle, Germany.
  • Center for Intervention and Research on Adaptive and Maladaptive Brain Circuits Underlying Mental Health (C-I-R-C), Site Jena Magdeburg Halle, Halle, Germany.
  • Department of Diagnostic and Interventional Radiology, Medical Center - University of Freiburg, Faculty of Medicine - University of Freiburg, Freiburg, Germany.
  • Institute of Epidemiology and Social Medicine, University of Münster, Münster, Germany.
  • Department of Psychiatry and Psychotherapy, University Medicine Greifswald, Greifswald, Germany.
  • Molecular Epidemiology Research Group, Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany.
  • Biobank Technology Platform, Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany.
  • Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • Institute of Social Medicine, Epidemiology and Health Economics, Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Institute of Clinical Epidemiology and Biometry, University of Würzburg, Würzburg, Germany.
  • State Institute of Health I, Bavarian Health and Food Safety Authority, Erlangen, Germany.
  • Department of Epidemiology and Preventive Medicine, University of Regensburg, Regensburg, Germany.
  • Institute of Social Medicine, Occupational Medicine and Public Health, Medical Faculty, University of Leipzig, Leipzig, Germany.
  • Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin Ultrahigh Field Facility (B.U.F.F.), Berlin, Germany.
  • Institute of Medical Psychology, Ludwig-Maximilians-Universität München (LMU), Munich, Germany.
  • Institute of Epidemiology, Helmholtz Zentrum München - German Research Center for Environmental Health (GmbH), Neuherberg, Germany.
  • Chair of Epidemiology, Institute for Medical Information Processing, Biometry and Epidemiology, Medical Faculty, Ludwig-Maximilians-Universität München, Munich, Germany.
  • German Center for Mental Health (DZPG), Partner Site Munich, Munich, Germany.
  • Department of Psychiatry, University of Münster, Münster, Germany.
  • Hertie Institute for AI in Brain Health, University of Tübingen, Tübingen, Germany.
  • Tübingen AI Center, University of Tübingen, Tübingen, Germany.
  • German Center for Mental Health (DZPG), Partner Site Tübingen, Tübingen, Germany.
  • Department of Psychiatry and Psychotherapy, University of Marburg, University Hospital UKGM, Marburg, Germany.
  • Department of Molecular Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany.
  • Institute of Nutritional Science, University of Potsdam, Nuthetal, Germany.
  • Division of Cancer Epidemiology, German Cancer Research Center (DKFZ) Heidelberg, Heidelberg, Germany.

Abstract

Alcohol use is linked to distributed structural brain alterations, but population-level alcohol-related neurobiology remains difficult to quantify. We tested whether deep learning-derived MRI representations capture reproducible variation in alcohol consumption severity and converge with clinical and biological markers. Representations were extracted from gray-matter volume maps in the German National Cohort (NAKO; N ≈ 28,000). Ridge-regression scores were derived from structural MRI to estimate alcohol consumption severity, measured with the Alcohol Use Disorders Identification Test-Consumption (AUDIT-C). Models were trained in NAKO, externally validated in UK Biobank (N ≈ 25,000), evaluated in FOR2107 (N ≈ 1900), and tested against ICD-10 alcohol use disorder (AUD), alcohol-related biomarkers, and cognition. In NAKO, the structural MRI-derived ridge-regression score correlated with measured AUDIT-C severity (r = 0.11; 95% CI, 0.09-0.12; q<sub>FDR</sub> = 1.2 × 10<sup>-70</sup>; MAE = 1.64). This association replicated in UK Biobank (r = 0.09; 95% CI, 0.07-0.10; q<sub>FDR</sub> = 4.9 × 10<sup>-41</sup>; MAE = 1.96) and generalized to AUD, with higher odds in the highest versus lowest brain-score quintile (OR = 2.28; 95% CI, 1.49-3.48; q<sub>FDR</sub> = 3.9 × 10<sup>-4</sup>). The score was associated with gamma-glutamyl transferase (β = 1.17 U/L; q<sub>FDR</sub> = 0.007), mean corpuscular volume (β = 14.26 fL; q<sub>FDR</sub> = 4.4 × 10<sup>-4</sup>), and slower reaction time (β = 163.40 ms; q<sub>FDR</sub> = 3.0 × 10<sup>-5</sup>). Deep learning-derived structural MRI representations capture weak but reproducible alcohol-related brain variation that converges with AUD diagnosis, peripheral biomarkers, and cognition, supporting their use in population-level addiction neuroscience while underscoring limits for individual-level prediction.

Topics

AlcoholismBrainDeep LearningGray MatterJournal Article

Ready to Sharpen Your Edge?

Subscribe to join 11k+ peers who rely on RadAISlice. Get the essential weekly briefing that empowers you to navigate the future of radiology.

We respect your privacy. Unsubscribe at any time.